LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1013 | 5445 | 0.1866 | -0.1481 |
MCF7 | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1744 | 5905 | 0.2934 | 0.0972 |
MCF7 | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1011 | 5905 | 0.1713 | -0.1411 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 5850 | 5445 | 1.0778 | 1.0789 |
MCF7 | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 434 | 5445 | 0.0800 | -0.4480 |
MCF7 | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 6034 | 5445 | 1.1088 | 1.1080 |
MCF7 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 3449 | 5445 | 0.6335 | 0.5851 |
MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 2028 | 5445 | 0.3715 | 0.2075 |
MCF7 | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1046 | 5445 | 0.1919 | -0.1358 |
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1530 | 5905 | 0.2591 | 0.0471 |
MCF7 | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 359 | 5905 | 0.0608 | -0.4776 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1646 | 5905 | 0.2786 | 0.0840 |
MCF7 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5916 | 5905 | 1.0023 | 1.0024 |
MCF7 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 468 | 5445 | 0.0859 | -0.4251 |
MCF7 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5059 | 5905 | 0.8573 | 0.8579 |
MCF7 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1098 | 5445 | 0.2015 | -0.1148 |
MCF7 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1909 | 5445 | 0.3509 | 0.1747 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3216 | 5905 | 0.5449 | 0.4953 |
MCF7 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 4844 | 5905 | 0.8197 | 0.8176 |
MCF7 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1488 | 5445 | 0.2731 | 0.0338 |
MCF7 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 479 | 5445 | 0.0885 | -0.4181 |
MCF7 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1413 | 5445 | 0.2590 | 0.0062 |
MCF7 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 4391 | 5445 | 0.8027 | 0.7828 |
MCF7 | KIN001-043 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 4548 | 5445 | 0.8340 | 0.8226 |
MCF7 | BMS345541 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1593 | 5445 | 0.2926 | 0.0696 |